Literature DB >> 16407588

Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.

Michael W Bradbury1.   

Abstract

Hepatic steatosis is a growing public health concern. Nonalcoholic fatty liver is increasingly common in Western societies and may lead to steatohepatitis, fibrosis, and cirrhosis, possibly triggered by lipid peroxidation. The relation of fatty liver to obesity, type II diabetes, and/or metabolic syndrome is significant. One aspect these related disorders share is increased serum-free fatty acids, which may be taken up by hepatocytes. Uptake of fatty acids in excess of metabolic requirements will lead to storage as triglycerides, resulting in steatosis and providing substrate for lipid peroxidation. Fatty acid uptake may be crucial to understanding steatosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407588     DOI: 10.1152/ajpgi.00413.2005

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  97 in total

1.  Salinity stress-induced differentially expressed miRNAs and target genes in sea cucumbers Apostichopus japonicus.

Authors:  Yi Tian; Yanpeng Shang; Ran Guo; Yaqing Chang; Yanan Jiang
Journal:  Cell Stress Chaperones       Date:  2019-05-27       Impact factor: 3.667

2.  Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults.

Authors:  Yu-Cheng Lin; Shu-Tin Hsiao; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

3.  Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring.

Authors:  Thomas R Magee; Guang Han; Bindu Cherian; Omid Khorram; Michael G Ross; Mina Desai
Journal:  Am J Obstet Gynecol       Date:  2008-07-29       Impact factor: 8.661

4.  Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease.

Authors:  Chunjiong Wang; Wenli Liu; Liu Yao; Xuejiao Zhang; Xu Zhang; Chenji Ye; Hongfeng Jiang; Jinlong He; Yi Zhu; Ding Ai
Journal:  Br J Pharmacol       Date:  2017-06-09       Impact factor: 8.739

5.  The effects of α-lipoic acid on liver oxidative stress and free fatty acid composition in methionine-choline deficient diet-induced NAFLD.

Authors:  Milena N Stanković; Dušan Mladenović; Milica Ninković; Ivana Ethuričić; Slađana Sobajić; Bojan Jorgačević; Silvio de Luka; Rada Jesic Vukicevic; Tatjana S Radosavljević
Journal:  J Med Food       Date:  2013-12-10       Impact factor: 2.786

Review 6.  Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

7.  Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice.

Authors:  Maxwell Afari Gyamfi; Yuji Tanaka; Lin He; Curtis D Klaassen; Yu-Jui Yvonne Wan
Journal:  Toxicol Appl Pharmacol       Date:  2008-10-08       Impact factor: 4.219

8.  Nonalcoholic fatty pancreas disease.

Authors:  Abhishek Mathur; Megan Marine; Debao Lu; Deborah A Swartz-Basile; Romil Saxena; Nicholas J Zyromski; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

9.  Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress.

Authors:  Keisuke Yamamoto; Kazuna Takahara; Seiichi Oyadomari; Tetsuya Okada; Takashi Sato; Akihiro Harada; Kazutoshi Mori
Journal:  Mol Biol Cell       Date:  2010-07-14       Impact factor: 4.138

10.  Alleviation of high-fat diet-induced fatty liver damage in group IVA phospholipase A2-knockout mice.

Authors:  Hiromi Ii; Naoki Yokoyama; Shintaro Yoshida; Kae Tsutsumi; Shinji Hatakeyama; Takashi Sato; Keiichi Ishihara; Satoshi Akiba
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.